News

July 1 - NBE-Therapeutics site-specific antibody conjugation technology published

Read more

February 20 - NBE-Therapeutics closes CHF 3.0 Mio series A financing

Read more

January 20 - Renowned Clinical Oncologist Prof. Zippelius joins NBE-Therapeutics Scientific Advisory Board

Read more